Functional Study of HTRA1 and Age-Related Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2008 - March 31, 2010
Grant ID
M2008092
Goals
Identification and functional studies of the HTRA1, a gene that has substantial impact on the risk of AMD, may define key molecular pathways involved in its pathogenesis. The experiments will yield novel mechanistic insights relevant to the pathogenesis of both early and late AMD. This may lead to therapies directed at the underlying cause and pre-symptomatic diagnosis leading to earlier intervention.
Summary
Identification and functional studies of the HTRA1, a gene that has substantial impact on the risk of AMD, may define key molecular pathways involved in its pathogenesis. The experiments will yield novel mechanistic insights relevant to the pathogenesis of both early and late AMD. This may lead to therapies directed at the underlying cause and pre-symptomatic diagnosis leading to earlier intervention.
Related Grants
Macular Degeneration Research
How Aging of the Immune System Affects Age-Related Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Masayuki Hata, MD, PhD
Current Organization
Kyoto University
How Aging of the Immune System Affects Age-Related Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Masayuki Hata, MD, PhD
Current Organization
Kyoto University
Macular Degeneration Research
Microglia’s Roles in AMD to Inform Therapies for Vision Loss Prevention
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Nobuhiko Shiraki, PhD
Current Organization
Duke University School of Medicine
Microglia’s Roles in AMD to Inform Therapies for Vision Loss Prevention
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Nobuhiko Shiraki, PhD
Current Organization
Duke University School of Medicine
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital